You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced/metastatic disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer Trial in La Jolla (CBI, CBI plus SBRT)

Active, not recruiting
  • Metastatic Cancer
  • La Jolla, California
    UCSD Moores Cancer Center
May 16, 2022

Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Later-line therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 10, 2023

Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

Recruiting
  • Advanced Cholangiocarcinoma
  • +6 more
  • Biospecimen Collection
  • +3 more
  • Los Angeles, California
  • +1 more
Mar 31, 2023

Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • (no location specified)
Oct 24, 2023

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

Advanced or Metastatic NSCLC Trial in Moscow, Saint Petersburg, St. Petersburg (Ceralasertib, Durvalumab)

Recruiting
  • Advanced or Metastatic NSCLC
  • Moscow, Russian Federation
  • +7 more
Jul 4, 2023

Human Epidermal Growth Factor Receptor 2-Positive Unresectable

Active, not recruiting
  • Metastatic Breast Cancer
  • Locally Advanced Breast Cancer
    • Athens, Greece
    • +1 more
    Jun 20, 2022

    Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

    Recruiting
    • Locally Advanced Neuroendocrine Neoplasm
    • Metastatic Neuroendocrine Neoplasm
    • Placebo Administration
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2023

    Family, End of Life, Cancer Metastatic Trial in Stockholm (Narstaende.se)

    Recruiting
    • Family
    • +3 more
    • Narstaende.se
    • Stockholm, Sweden
      Marie Cederschiöld University
    Mar 14, 2023

    Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)

    Not yet recruiting
    • Cancer
    • +8 more
    • DK210 (EGFR)
    • +3 more
    • (no location specified)
    Jan 27, 2023

    Metastatic Breast Cancer Trial in Shanghai (Trastuzumab, pyrotinib, Dalpiciclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Oct 11, 2022

    Distress Associated With Coronavirus Disease 2019 and Telehealth

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +6 more
    • Survey Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 16, 2022

    Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Hospitalet de Llobregat, Barcelona, Spain
    • +6 more
    Jan 23, 2023

    Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

    Not yet recruiting
    • Solid Tumor, Adult
    • +4 more
    • (no location specified)
    Apr 24, 2023

    A NIS of Alpelisib in Combination With Fulvestrant in

    Not yet recruiting
    • Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
    • Alpelisib
    • Fulvestrant
    • (no location specified)
    Aug 9, 2022

    Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

    Not yet recruiting
    • Metastatic Melanoma
    • Advanced Melanoma
    • San Francisco, California
      University of California, San Francisco
    Jan 13, 2023

    Advanced Malignant Solid Tumor, Hepatocellular Carcinoma Trial in Scottsdale (Laboratory Biomarker Analysis, Pharmacological

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • Hepatocellular Carcinoma
    • Laboratory Biomarker Analysis
    • +2 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Oct 6, 2021

    Advanced or Metastatic Cancer, Fear of Cancer Progression, Metacognition-based Intervention Trial (ConquerFear intervention,

    Not yet recruiting
    • Advanced or Metastatic Cancer
    • +4 more
    • ConquerFear intervention
    • +2 more
    • (no location specified)
    Jan 12, 2023

    Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • (no location specified)
    Oct 26, 2023

    Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2

    Recruiting
    • Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment
    • Duarte, California
    • +12 more
    Jul 6, 2022

    Melanoma (Skin), Cutaneous Melanoma, Adult Disease Trial in France, Spain, United States (ANV419, Pembrolizumab, Ipilimumab)

    Recruiting
    • Melanoma (Skin)
    • +4 more
    • Bloomington, Minnesota
    • +7 more
    Jan 31, 2023

    Advanced Breast Cancer Trial in Puerto Rico, United States (ARV-471, Fulvestrant)

    Recruiting
    • Advanced Breast Cancer
    • Coconut Creek, Florida
    • +13 more
    Jan 27, 2023

    Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Springfield, Massachusetts
    • +2 more
    Nov 1, 2022

    NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Telisotuzumab Vedotin
    • +4 more
    • (no location specified)
    Oct 17, 2023

    Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

    Not yet recruiting
    • Pancreatic Cancer Metastatic
    • C3 (Metformin, Simvastatin, and Digoxin)
    • (no location specified)
    Sep 1, 2023